Literature DB >> 11418935

Mu-opioid receptors in the ventral tegmental area are targeted to presynaptically and directly modulate mesocortical projection neurons.

A L Svingos1, M Garzón, E E Colago, V M Pickel.   

Abstract

Mesocorticolimbic projections originating from dopaminergic and GABAergic neurons in the ventral tegmental area (VTA) play a critical role in opiate addiction. Activation of mu-opioid receptors (MOR), which are located mainly within inhibitory neurons in the VTA, results in enhanced dopaminergic transmission in target regions, including the medial prefrontal cortex (mPFC). We combined retrograde tract-tracing and electron microscopic immunocytochemistry to determine if neurons in the VTA that project to the mPFC contain MOR or receive input from MOR-containing terminals. Rats received unilateral injections of the retrograde tracer Fluoro-Gold (FG) into the mPFC. Tissue sections throughout the VTA were then processed for electron microscopic examination of FG and MOR. Immunoperoxidase labeling for FG was present in VTA cell bodies that contained immunogold-silver particles for MOR that often were contacted by profiles exclusively immunoreactive for MOR, including somata and axon terminals. The majority of dually labeled profiles were dendrites that received convergent input from unlabeled axon terminals forming either symmetric or asymmetric type synapses. Within retrogradely labeled cell bodies and proximal dendrites, MOR immunoreactivity was mainly sequestered within the cytoplasm. In contrast, distal retrogradely labeled dendrites contained MOR gold particles located along the plasma membranes. These data suggest that opiates active at MOR in the VTA modulate cortical activity through 1) presynaptic actions on MOR in terminals contacting mesocortical cell bodies, and 2) direct activation of MOR in distal dendrites of projection neurons. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11418935     DOI: 10.1002/syn.1079

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  18 in total

1.  Stress-induced activation of ventral tegmental mu-opioid receptors reduces accumbens dopamine tone by enhancing dopamine transmission in the medial pre-frontal cortex.

Authors:  Emanuele Claudio Latagliata; Alessandro Valzania; Tiziana Pascucci; Paolo Campus; Simona Cabib; Stefano Puglisi-Allegra
Journal:  Psychopharmacology (Berl)       Date:  2014-03-29       Impact factor: 4.530

Review 2.  The neurobiology of opiate motivation.

Authors:  Ryan Ting-A-Kee; Derek van der Kooy
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

3.  Dysregulation of regional endogenous opioid function in borderline personality disorder.

Authors:  Alan R Prossin; Tiffany M Love; Robert A Koeppe; Jon-Kar Zubieta; Kenneth R Silk
Journal:  Am J Psychiatry       Date:  2010-05-03       Impact factor: 18.112

4.  Ethanol blocks long-term potentiation of GABAergic synapses in the ventral tegmental area involving mu-opioid receptors.

Authors:  Yan-zhong Guan; Jiang-Hong Ye
Journal:  Neuropsychopharmacology       Date:  2010-04-14       Impact factor: 7.853

5.  Microinjection of the delta-opioid receptor selective antagonist naltrindole 5'-isothiocyanate site specifically affects cocaine self-administration in rats responding under a progressive ratio schedule of reinforcement.

Authors:  Sara Jane Ward; David C S Roberts
Journal:  Behav Brain Res       Date:  2007-05-18       Impact factor: 3.332

6.  Region-specific changes in the subcellular distribution of AMPA receptor GluR1 subunit in the rat ventral tegmental area after acute or chronic morphine administration.

Authors:  Diane A Lane; Andree A Lessard; June Chan; Eric E O Colago; Yan Zhou; Stefan D Schlussman; Mary Jeanne Kreek; Virginia M Pickel
Journal:  J Neurosci       Date:  2008-09-24       Impact factor: 6.167

Review 7.  Metabolic hormones, dopamine circuits, and feeding.

Authors:  Nandakumar S Narayanan; Douglas J Guarnieri; Ralph J DiLeone
Journal:  Front Neuroendocrinol       Date:  2009-10-28       Impact factor: 8.606

8.  Mu opioid receptor modulation of somatodendritic dopamine overflow: GABAergic and glutamatergic mechanisms.

Authors:  V I Chefer; L Denoroy; A Zapata; T S Shippenberg
Journal:  Eur J Neurosci       Date:  2009-07-15       Impact factor: 3.386

Review 9.  Drug withdrawal conceptualized as a stressor.

Authors:  Elena H Chartoff; William A Carlezon
Journal:  Behav Pharmacol       Date:  2014-09       Impact factor: 2.293

10.  The neurokinin-3 (NK3) and the neurokinin-1 (NK1) receptors are differentially targeted to mesocortical and mesolimbic projection neurons and to neuronal nuclei in the rat ventral tegmental area.

Authors:  Andrée Lessard; Martin Savard; Fernand Gobeil; Joseph P Pierce; Virginia M Pickel
Journal:  Synapse       Date:  2009-06       Impact factor: 2.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.